NCT03525275

Brief Summary

The purpose of this randomized clinical trial is to determine the effectiveness of Battlefield Acupuncture (BFA) in addition to usual post-surgical shoulder physical therapy compared to a standard shoulder rehabilitation program in reducing medication use and pain in patients who have undergone shoulder surgery. Measurements of medication (opioid, NSAID, acetaminophen, etc.) use (daily number of pills consumed), pain rating, patient specific functional scale and global rating of change will be taken at 24, 72 hours, 7 days, 14 days and at six weeks post-surgery. It is hypothesized that the inclusion of Battlefield Acupuncture will result in a decrease in medication use and post-surgical pain when compared to rehabilitation alone. The population for this study is male and female DoD beneficiaries, ages 17-55 (17 if cadet) that are not participating in other shoulder research studies. The subjects in the experimental group will receive Battlefield Acupuncture in addition to their respective post-surgical shoulder rehabilitation protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 15, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

August 15, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2019

Completed
Last Updated

May 20, 2019

Status Verified

May 1, 2019

Enrollment Period

8 months

First QC Date

April 27, 2018

Last Update Submit

May 16, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Pain medication use

    Patient log of daily pain medication use (opioid, NSAID, acetaminophen), the number of pills per medication will be logged daily over the course of 6 weeks

    daily log, comparison at 24hours, 72hours, 1 week, 2 weeks, 6 weeks

  • Change in Visual Analog Pain scale report

    patient's perceived pain on the Visual Analog Scale, 0 to 100mm scale with higher equaling more pain perceived by the subject, 0 = no pain and 10= worst pain imaginable.

    outcome comparison at 24hours, 72hours, 1 week, 2 weeks, 6 weeks

Secondary Outcomes (2)

  • Change in Global Rating of Change (GROC)

    outcome comparison at 24 hours, 72hours, 1 week, 2 weeks, 6 weeks

  • Change in Patient Specific Functional Scale (PSFS)

    outcome comparison at 24 hours, 72hours, 1 week, 2 weeks, 6 weeks

Study Arms (2)

BFA with Physical Therapy

EXPERIMENTAL

BFA + post-surgical protocol, intervention = battlefield acupuncture plus post-surgical protocol

Device: Battlefield AcupunctureProcedure: Post-surgical shoulder protocol

Physical Therapy alone

ACTIVE COMPARATOR

Intervention = Post-surgical protocol

Procedure: Post-surgical shoulder protocol

Interventions

Battlefield Acupuncture uses ASP semi-permanent needles inserted into their ears for pain attenuation in 5 known points. Both groups receive their respective post-surgical rehabilitation protocols

BFA with Physical Therapy

Surgery specific post-surgical physical therapy protocol

BFA with Physical TherapyPhysical Therapy alone

Eligibility Criteria

Age17 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Department of Defense beneficiaries ages 17-55, prior to or recent (within 24 hrs) shoulder surgery

You may not qualify if:

  • Self-reported pregnancy, History of blood borne pathogens/infectious disease/active infection/metal allergy, bleeding disorders or currently taking anti-coagulant medications, Participants who are not fluent in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keller Army Community Hospital

West Point, New York, 10996, United States

Location

MeSH Terms

Conditions

Pain, PostoperativeBankart LesionsShoulder Impingement SyndromeRotator Cuff InjuriesShoulder Dislocation

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsShoulder FracturesFractures, BoneWounds and InjuriesShoulder InjuriesJoint DiseasesMusculoskeletal DiseasesRuptureTendon InjuriesJoint Dislocations

Study Officials

  • Keith M Collinsworth, DPT

    Keller ACH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 x 5 Mixed model ANOVA
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

April 27, 2018

First Posted

May 15, 2018

Study Start

August 15, 2018

Primary Completion

April 15, 2019

Study Completion

April 15, 2019

Last Updated

May 20, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations